Algert Global LLC Sells 23,150 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• Algert Global LLC reduced its stake in Bath & Body Works by 9.7% during the first quarter, selling 23,150 shares and holding approximately 0.10% of the company worth $6.5 million.
• Wells Fargo increased its target price on Bath & Body Works shares from $40.00 to $44.00, reflecting a positive outlook with an "overweight" rating.
• The company declared a quarterly dividend of $0.20 per share, representing an annualized dividend of $0.80 and a yield of 2.8%.

Algert Global LLC cut its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 9.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 214,867 shares of the company's stock after selling 23,150 shares during the period. Algert Global LLC owned 0.10% of Bath & Body Works worth $6,515,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Fox Run Management L.L.C. lifted its holdings in Bath & Body Works by 264.3% in the first quarter. Fox Run Management L.L.C. now owns 72,189 shares of the company's stock worth $2,189,000 after buying an additional 52,372 shares during the period. Boston Partners lifted its holdings in Bath & Body Works by 289.7% in the first quarter. Boston Partners now owns 937,024 shares of the company's stock worth $28,292,000 after buying an additional 696,555 shares during the period. Caitong International Asset Management Co. Ltd lifted its holdings in Bath & Body Works by 9,569.1% in the first quarter. Caitong International Asset Management Co. Ltd now owns 11,893 shares of the company's stock worth $361,000 after buying an additional 11,770 shares during the period. GKV Capital Management Co. Inc. purchased a new stake in Bath & Body Works in the first quarter worth about $69,000. Finally, Russell Investments Group Ltd. lifted its holdings in Bath & Body Works by 10.8% in the first quarter. Russell Investments Group Ltd. now owns 191,916 shares of the company's stock worth $5,819,000 after buying an additional 18,708 shares during the period. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Stock Performance

Shares of BBWI traded up $1.6350 on Friday, hitting $31.0550. 4,792,107 shares of the stock traded hands, compared to its average volume of 4,610,963. The company has a market capitalization of $6.57 billion, a PE ratio of 8.28, a P/E/G ratio of 0.99 and a beta of 1.54. The business has a 50 day simple moving average of $30.30 and a 200 day simple moving average of $31.03. Bath & Body Works, Inc. has a one year low of $24.94 and a one year high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.02. The company had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.42 billion. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The firm's quarterly revenue was up 2.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.38 earnings per share. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. On average, equities analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date of this dividend is Friday, August 22nd. Bath & Body Works's payout ratio is 21.33%.

Analyst Ratings Changes

Several brokerages have commented on BBWI. Wells Fargo & Company raised their price objective on shares of Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a report on Wednesday, May 14th. JPMorgan Chase & Co. lifted their target price on shares of Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a report on Monday, July 28th. Telsey Advisory Group reiterated an "outperform" rating and set a $38.00 target price on shares of Bath & Body Works in a report on Thursday. Barclays lowered their target price on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a report on Friday, May 30th. Finally, The Goldman Sachs Group lowered their target price on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a report on Friday, May 30th. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $42.06.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.